nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—atopic dermatitis	0.413	1	CbGaD
Chloroquine—CYP2C8—Mometasone—atopic dermatitis	0.0454	0.111	CbGbCtD
Chloroquine—CYP3A5—Tacrolimus—atopic dermatitis	0.0371	0.0904	CbGbCtD
Chloroquine—CYP2C8—Loratadine—atopic dermatitis	0.0261	0.0637	CbGbCtD
Chloroquine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0243	0.0593	CbGbCtD
Chloroquine—ABCB1—Tacrolimus—atopic dermatitis	0.0241	0.0589	CbGbCtD
Chloroquine—ABCB1—Loratadine—atopic dermatitis	0.0177	0.0431	CbGbCtD
Chloroquine—CYP2D6—Loratadine—atopic dermatitis	0.0166	0.0406	CbGbCtD
Chloroquine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0166	0.0406	CbGbCtD
Chloroquine—ABCB1—Methylprednisolone—atopic dermatitis	0.0161	0.0394	CbGbCtD
Chloroquine—CYP1A1—Dexamethasone—atopic dermatitis	0.0156	0.0382	CbGbCtD
Chloroquine—CYP3A5—Hydrocortisone—atopic dermatitis	0.0151	0.0368	CbGbCtD
Chloroquine—CYP2C8—Hydrocortisone—atopic dermatitis	0.0145	0.0354	CbGbCtD
Chloroquine—CYP3A4—Tacrolimus—atopic dermatitis	0.0144	0.0353	CbGbCtD
Chloroquine—CYP3A4—Loratadine—atopic dermatitis	0.0106	0.0258	CbGbCtD
Chloroquine—ABCB1—Betamethasone—atopic dermatitis	0.0105	0.0256	CbGbCtD
Chloroquine—ABCB1—Prednisolone—atopic dermatitis	0.0104	0.0253	CbGbCtD
Chloroquine—ABCB1—Hydrocortisone—atopic dermatitis	0.00982	0.024	CbGbCtD
Chloroquine—ABCB1—Prednisone—atopic dermatitis	0.00978	0.0239	CbGbCtD
Chloroquine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00967	0.0236	CbGbCtD
Chloroquine—CYP3A5—Dexamethasone—atopic dermatitis	0.00938	0.0229	CbGbCtD
Chloroquine—CYP2C8—Dexamethasone—atopic dermatitis	0.00902	0.022	CbGbCtD
Chloroquine—CYP3A4—Triamcinolone—atopic dermatitis	0.00733	0.0179	CbGbCtD
Chloroquine—CYP3A4—Betamethasone—atopic dermatitis	0.00629	0.0154	CbGbCtD
Chloroquine—CYP3A4—Prednisolone—atopic dermatitis	0.00621	0.0151	CbGbCtD
Chloroquine—ABCB1—Dexamethasone—atopic dermatitis	0.00611	0.0149	CbGbCtD
Chloroquine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00588	0.0144	CbGbCtD
Chloroquine—CYP3A4—Prednisone—atopic dermatitis	0.00586	0.0143	CbGbCtD
Chloroquine—CYP2D6—Dexamethasone—atopic dermatitis	0.00575	0.014	CbGbCtD
Chloroquine—CYP3A4—Dexamethasone—atopic dermatitis	0.00366	0.00893	CbGbCtD
Chloroquine—Skin exfoliation—Hydrocortisone—atopic dermatitis	0.000341	0.00277	CcSEcCtD
Chloroquine—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.000337	0.00274	CcSEcCtD
Chloroquine—Decreased appetite—Diphenhydramine—atopic dermatitis	0.000337	0.00274	CcSEcCtD
Chloroquine—Agitation—Loratadine—atopic dermatitis	0.000337	0.00273	CcSEcCtD
Chloroquine—Neutropenia—Tacrolimus—atopic dermatitis	0.000336	0.00273	CcSEcCtD
Chloroquine—Rash—Desonide—atopic dermatitis	0.000335	0.00272	CcSEcCtD
Chloroquine—Angioedema—Loratadine—atopic dermatitis	0.000335	0.00272	CcSEcCtD
Chloroquine—Alopecia—Fluocinolone Acetonide—atopic dermatitis	0.000334	0.00271	CcSEcCtD
Chloroquine—Headache—Desonide—atopic dermatitis	0.000333	0.0027	CcSEcCtD
Chloroquine—Photosensitivity reaction—Tacrolimus—atopic dermatitis	0.000328	0.00266	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000324	0.00263	CcSEcCtD
Chloroquine—Skin exfoliation—Triamcinolone—atopic dermatitis	0.000321	0.00261	CcSEcCtD
Chloroquine—Skin exfoliation—Methylprednisolone—atopic dermatitis	0.00032	0.0026	CcSEcCtD
Chloroquine—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00032	0.0026	CcSEcCtD
Chloroquine—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00032	0.0026	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Tacrolimus—atopic dermatitis	0.000317	0.00258	CcSEcCtD
Chloroquine—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00031	0.00252	CcSEcCtD
Chloroquine—Delirium—Prednisone—atopic dermatitis	0.000309	0.00251	CcSEcCtD
Chloroquine—Urticaria—Dimenhydrinate—atopic dermatitis	0.000308	0.0025	CcSEcCtD
Chloroquine—Urticaria—Diphenhydramine—atopic dermatitis	0.000308	0.0025	CcSEcCtD
Chloroquine—Pruritus—Fluocinonide—atopic dermatitis	0.000305	0.00247	CcSEcCtD
Chloroquine—Anaphylactic shock—Loratadine—atopic dermatitis	0.000299	0.00243	CcSEcCtD
Chloroquine—Agranulocytosis—Tacrolimus—atopic dermatitis	0.000299	0.00243	CcSEcCtD
Chloroquine—Urticaria—Pimecrolimus—atopic dermatitis	0.000298	0.00242	CcSEcCtD
Chloroquine—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000297	0.00241	CcSEcCtD
Chloroquine—Skin exfoliation—Dexamethasone—atopic dermatitis	0.000291	0.00236	CcSEcCtD
Chloroquine—Skin exfoliation—Betamethasone—atopic dermatitis	0.000291	0.00236	CcSEcCtD
Chloroquine—Hepatitis—Tacrolimus—atopic dermatitis	0.000287	0.00233	CcSEcCtD
Chloroquine—Angioedema—Mometasone—atopic dermatitis	0.000287	0.00233	CcSEcCtD
Chloroquine—Hallucination—Tacrolimus—atopic dermatitis	0.000286	0.00232	CcSEcCtD
Chloroquine—Visual disturbance—Prednisolone—atopic dermatitis	0.00028	0.00227	CcSEcCtD
Chloroquine—Hypotension—Loratadine—atopic dermatitis	0.000279	0.00227	CcSEcCtD
Chloroquine—Asthenia—Dimenhydrinate—atopic dermatitis	0.000279	0.00226	CcSEcCtD
Chloroquine—Asthenia—Diphenhydramine—atopic dermatitis	0.000279	0.00226	CcSEcCtD
Chloroquine—Visual impairment—Tacrolimus—atopic dermatitis	0.000277	0.00225	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Prednisolone—atopic dermatitis	0.000274	0.00223	CcSEcCtD
Chloroquine—Erythema multiforme—Tacrolimus—atopic dermatitis	0.000272	0.00221	CcSEcCtD
Chloroquine—Rash—Fluocinonide—atopic dermatitis	0.000271	0.0022	CcSEcCtD
Chloroquine—Insomnia—Loratadine—atopic dermatitis	0.00027	0.0022	CcSEcCtD
Chloroquine—Headache—Fluocinonide—atopic dermatitis	0.00027	0.00219	CcSEcCtD
Chloroquine—Tinnitus—Tacrolimus—atopic dermatitis	0.000268	0.00218	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Hydrocortisone—atopic dermatitis	0.000268	0.00217	CcSEcCtD
Chloroquine—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000266	0.00216	CcSEcCtD
Chloroquine—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000266	0.00216	CcSEcCtD
Chloroquine—Pruritus—Pimecrolimus—atopic dermatitis	0.000266	0.00216	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000258	0.0021	CcSEcCtD
Chloroquine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000257	0.00209	CcSEcCtD
Chloroquine—Anaphylactic shock—Mometasone—atopic dermatitis	0.000257	0.00208	CcSEcCtD
Chloroquine—Alopecia—Tacrolimus—atopic dermatitis	0.000254	0.00206	CcSEcCtD
Chloroquine—Skin exfoliation—Prednisone—atopic dermatitis	0.000254	0.00206	CcSEcCtD
Chloroquine—Psychotic disorder—Hydrocortisone—atopic dermatitis	0.000253	0.00206	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Triamcinolone—atopic dermatitis	0.000252	0.00205	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methylprednisolone—atopic dermatitis	0.000252	0.00204	CcSEcCtD
Chloroquine—Vomiting—Diphenhydramine—atopic dermatitis	0.000247	0.002	CcSEcCtD
Chloroquine—Vomiting—Dimenhydrinate—atopic dermatitis	0.000247	0.002	CcSEcCtD
Chloroquine—Feeling abnormal—Loratadine—atopic dermatitis	0.000246	0.002	CcSEcCtD
Chloroquine—Rash—Dimenhydrinate—atopic dermatitis	0.000245	0.00199	CcSEcCtD
Chloroquine—Rash—Diphenhydramine—atopic dermatitis	0.000245	0.00199	CcSEcCtD
Chloroquine—Anorexia—Mometasone—atopic dermatitis	0.000245	0.00199	CcSEcCtD
Chloroquine—Headache—Diphenhydramine—atopic dermatitis	0.000243	0.00197	CcSEcCtD
Chloroquine—Headache—Dimenhydrinate—atopic dermatitis	0.000243	0.00197	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL2—atopic dermatitis	0.000239	0.00442	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—NFKBIA—atopic dermatitis	0.000239	0.00442	CbGpPWpGaD
Chloroquine—Vomiting—Pimecrolimus—atopic dermatitis	0.000239	0.00194	CcSEcCtD
Chloroquine—Psychotic disorder—Methylprednisolone—atopic dermatitis	0.000238	0.00193	CcSEcCtD
Chloroquine—Rash—Pimecrolimus—atopic dermatitis	0.000237	0.00192	CcSEcCtD
Chloroquine—Abdominal pain—Loratadine—atopic dermatitis	0.000236	0.00192	CcSEcCtD
Chloroquine—Vision blurred—Tacrolimus—atopic dermatitis	0.000236	0.00191	CcSEcCtD
Chloroquine—Headache—Pimecrolimus—atopic dermatitis	0.000235	0.00191	CcSEcCtD
Chloroquine—Visual disturbance—Dexamethasone—atopic dermatitis	0.000234	0.0019	CcSEcCtD
Chloroquine—Visual disturbance—Betamethasone—atopic dermatitis	0.000234	0.0019	CcSEcCtD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL1B—atopic dermatitis	0.000233	0.0043	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000232	0.00188	CcSEcCtD
Chloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—atopic dermatitis	0.000232	0.00429	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL2—atopic dermatitis	0.000232	0.00429	CbGpPWpGaD
Chloroquine—Nausea—Dimenhydrinate—atopic dermatitis	0.000231	0.00187	CcSEcCtD
Chloroquine—Nausea—Diphenhydramine—atopic dermatitis	0.000231	0.00187	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL8—atopic dermatitis	0.00023	0.00425	CbGpPWpGaD
Chloroquine—Agitation—Tacrolimus—atopic dermatitis	0.00023	0.00187	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Dexamethasone—atopic dermatitis	0.000229	0.00186	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Betamethasone—atopic dermatitis	0.000229	0.00186	CcSEcCtD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK8—atopic dermatitis	0.000228	0.00421	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	0.000227	0.0042	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000225	0.00415	CbGpPWpGaD
Chloroquine—Decreased appetite—Mometasone—atopic dermatitis	0.000223	0.00181	CcSEcCtD
Chloroquine—Nausea—Pimecrolimus—atopic dermatitis	0.000223	0.00181	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	0.000221	0.00408	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—atopic dermatitis	0.00022	0.00406	CbGpPWpGaD
Chloroquine—Convulsion—Tacrolimus—atopic dermatitis	0.000217	0.00176	CcSEcCtD
Chloroquine—Psychotic disorder—Dexamethasone—atopic dermatitis	0.000216	0.00176	CcSEcCtD
Chloroquine—Psychotic disorder—Betamethasone—atopic dermatitis	0.000216	0.00176	CcSEcCtD
Chloroquine—TNF—TWEAK Signaling Pathway—CASP8—atopic dermatitis	0.000215	0.00398	CbGpPWpGaD
Chloroquine—TNF—FAS pathway and Stress induction of HSP regulation—CASP8—atopic dermatitis	0.000215	0.00398	CbGpPWpGaD
Chloroquine—TNF—Ceramide signaling pathway—NFKBIA—atopic dermatitis	0.000215	0.00397	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—atopic dermatitis	0.000215	0.00397	CbGpPWpGaD
Chloroquine—Asthenia—Loratadine—atopic dermatitis	0.000215	0.00174	CcSEcCtD
Chloroquine—Anxiety—Tacrolimus—atopic dermatitis	0.000212	0.00172	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—IL4—atopic dermatitis	0.000211	0.0039	CbGpPWpGaD
Chloroquine—TLR9—Immune System—FCER1A—atopic dermatitis	0.000207	0.00383	CbGpPWpGaD
Chloroquine—Confusional state—Tacrolimus—atopic dermatitis	0.000206	0.00167	CcSEcCtD
Chloroquine—Diarrhoea—Loratadine—atopic dermatitis	0.000205	0.00166	CcSEcCtD
Chloroquine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000204	0.00166	CcSEcCtD
Chloroquine—TNF—Monoamine Transport—IL1B—atopic dermatitis	0.000203	0.00376	CbGpPWpGaD
Chloroquine—Abdominal pain—Mometasone—atopic dermatitis	0.000203	0.00165	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IFNG—atopic dermatitis	0.000203	0.00375	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.000202	0.00374	CbGpPWpGaD
Chloroquine—TNF—TNF receptor signaling pathway —CASP8—atopic dermatitis	0.0002	0.0037	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—STAT6—atopic dermatitis	0.0002	0.0037	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.0002	0.00162	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—TLR2—atopic dermatitis	0.0002	0.0037	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—CD4—atopic dermatitis	0.000196	0.00362	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CARD11—atopic dermatitis	0.000195	0.0036	CbGpPWpGaD
Chloroquine—Anorexia—Tacrolimus—atopic dermatitis	0.000195	0.00158	CcSEcCtD
Chloroquine—TNF—Ceramide signaling pathway—CASP8—atopic dermatitis	0.000194	0.00358	CbGpPWpGaD
Chloroquine—TLR9—Immune System—MS4A2—atopic dermatitis	0.000192	0.00356	CbGpPWpGaD
Chloroquine—Hypotension—Tacrolimus—atopic dermatitis	0.000191	0.00155	CcSEcCtD
Chloroquine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00019	0.00154	CcSEcCtD
Chloroquine—Vomiting—Loratadine—atopic dermatitis	0.00019	0.00154	CcSEcCtD
Chloroquine—Rash—Loratadine—atopic dermatitis	0.000189	0.00153	CcSEcCtD
Chloroquine—Psychotic disorder—Prednisone—atopic dermatitis	0.000188	0.00153	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL10—atopic dermatitis	0.000188	0.00347	CbGpPWpGaD
Chloroquine—Headache—Loratadine—atopic dermatitis	0.000187	0.00152	CcSEcCtD
Chloroquine—Insomnia—Tacrolimus—atopic dermatitis	0.000185	0.0015	CcSEcCtD
Chloroquine—Asthenia—Mometasone—atopic dermatitis	0.000184	0.00149	CcSEcCtD
Chloroquine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000184	0.00149	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL4—atopic dermatitis	0.000183	0.00338	CbGpPWpGaD
Chloroquine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—MAPK8—atopic dermatitis	0.000182	0.00336	CbGpPWpGaD
Chloroquine—Pruritus—Mometasone—atopic dermatitis	0.000182	0.00147	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IL1B—atopic dermatitis	0.000181	0.00334	CbGpPWpGaD
Chloroquine—TNF—Overview of nanoparticle effects—IL6—atopic dermatitis	0.00018	0.00334	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL2—atopic dermatitis	0.00018	0.00333	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	0.00018	0.00332	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CXCL10—atopic dermatitis	0.000179	0.0033	CbGpPWpGaD
Chloroquine—Hallucination—Hydrocortisone—atopic dermatitis	0.000178	0.00145	CcSEcCtD
Chloroquine—Nausea—Loratadine—atopic dermatitis	0.000178	0.00144	CcSEcCtD
Chloroquine—Decreased appetite—Tacrolimus—atopic dermatitis	0.000178	0.00144	CcSEcCtD
Chloroquine—Visual impairment—Prednisolone—atopic dermatitis	0.000177	0.00144	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000176	0.00143	CcSEcCtD
Chloroquine—Diarrhoea—Mometasone—atopic dermatitis	0.000176	0.00143	CcSEcCtD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.000174	0.00322	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	0.000172	0.00319	CbGpPWpGaD
Chloroquine—TLR9—Immune System—DEFB1—atopic dermatitis	0.000172	0.00317	CbGpPWpGaD
Chloroquine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000171	0.00139	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.00017	0.00315	CbGpPWpGaD
Chloroquine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000169	0.00138	CcSEcCtD
Chloroquine—TNF—Caspase Cascade in Apoptosis—CASP8—atopic dermatitis	0.000169	0.00312	CbGpPWpGaD
Chloroquine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000168	0.00137	CcSEcCtD
Chloroquine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000168	0.00137	CcSEcCtD
Chloroquine—Hallucination—Methylprednisolone—atopic dermatitis	0.000168	0.00136	CcSEcCtD
Chloroquine—TNF—Transcriptional regulation of white adipocyte differentiation—PPARA—atopic dermatitis	0.000166	0.00308	CbGpPWpGaD
Chloroquine—Vomiting—Mometasone—atopic dermatitis	0.000163	0.00132	CcSEcCtD
Chloroquine—Visual impairment—Methylprednisolone—atopic dermatitis	0.000162	0.00132	CcSEcCtD
Chloroquine—Urticaria—Tacrolimus—atopic dermatitis	0.000162	0.00132	CcSEcCtD
Chloroquine—Rash—Mometasone—atopic dermatitis	0.000162	0.00131	CcSEcCtD
Chloroquine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000161	0.00131	CcSEcCtD
Chloroquine—Headache—Mometasone—atopic dermatitis	0.000161	0.00131	CcSEcCtD
Chloroquine—TNF—Transcription factor regulation in adipogenesis—IL6—atopic dermatitis	0.00016	0.00297	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.00016	0.00297	CbGpPWpGaD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	0.00016	0.00296	CbGpPWpGaD
Chloroquine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00016	0.0013	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	0.000159	0.00295	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000159	0.00294	CbGpPWpGaD
Chloroquine—TNF—Signaling events mediated by HDAC Class I—NFKBIA—atopic dermatitis	0.000159	0.00293	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	0.000158	0.00292	CbGpPWpGaD
Chloroquine—TNF—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000157	0.0029	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000156	0.00289	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—TLR2—atopic dermatitis	0.000156	0.00288	CbGpPWpGaD
Chloroquine—Neutropenia—Prednisone—atopic dermatitis	0.000156	0.00127	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000154	0.00285	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CCL5—atopic dermatitis	0.000154	0.00284	CbGpPWpGaD
Chloroquine—Hallucination—Dexamethasone—atopic dermatitis	0.000152	0.00124	CcSEcCtD
Chloroquine—Hallucination—Betamethasone—atopic dermatitis	0.000152	0.00124	CcSEcCtD
Chloroquine—Nausea—Mometasone—atopic dermatitis	0.000152	0.00124	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000152	0.00281	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CASP1—atopic dermatitis	0.000152	0.00281	CbGpPWpGaD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000151	0.0028	CbGpPWpGaD
Chloroquine—Vision blurred—Prednisolone—atopic dermatitis	0.000151	0.00122	CcSEcCtD
Chloroquine—TNF—FAS pathway and Stress induction of HSP regulation—MAPK8—atopic dermatitis	0.00015	0.00277	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—MAPK8—atopic dermatitis	0.00015	0.00277	CbGpPWpGaD
Chloroquine—TNF—TGF-beta Receptor Signaling—IFNG—atopic dermatitis	0.00015	0.00277	CbGpPWpGaD
Chloroquine—TLR9—IRS-mediated signalling—IL6—atopic dermatitis	0.000149	0.00276	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—CASP1—atopic dermatitis	0.000148	0.00274	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	0.000148	0.00274	CbGpPWpGaD
Chloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	0.000148	0.00274	CbGpPWpGaD
Chloroquine—Visual impairment—Betamethasone—atopic dermatitis	0.000148	0.0012	CcSEcCtD
Chloroquine—Visual impairment—Dexamethasone—atopic dermatitis	0.000148	0.0012	CcSEcCtD
Chloroquine—Asthenia—Tacrolimus—atopic dermatitis	0.000147	0.00119	CcSEcCtD
Chloroquine—Angioedema—Prednisolone—atopic dermatitis	0.000146	0.00119	CcSEcCtD
Chloroquine—TLR9—IRS-related events—IL6—atopic dermatitis	0.000145	0.00269	CbGpPWpGaD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	0.000145	0.00269	CbGpPWpGaD
Chloroquine—Pruritus—Tacrolimus—atopic dermatitis	0.000144	0.00117	CcSEcCtD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	0.000144	0.00266	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—BDNF—atopic dermatitis	0.000143	0.00264	CbGpPWpGaD
Chloroquine—Angioedema—Hydrocortisone—atopic dermatitis	0.000143	0.00116	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	0.000142	0.00262	CbGpPWpGaD
Chloroquine—TNF—IL27-mediated signaling events—IL6—atopic dermatitis	0.00014	0.0026	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	0.00014	0.00259	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—IL6—atopic dermatitis	0.00014	0.00259	CbGpPWpGaD
Chloroquine—TLR9—Insulin receptor signalling cascade—IL6—atopic dermatitis	0.00014	0.00259	CbGpPWpGaD
Chloroquine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00014	0.00259	CbGpPWpGaD
Chloroquine—TNF—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.00014	0.00259	CbGpPWpGaD
Chloroquine—Diarrhoea—Tacrolimus—atopic dermatitis	0.00014	0.00113	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CXCL10—atopic dermatitis	0.000139	0.00258	CbGpPWpGaD
Chloroquine—Convulsion—Prednisolone—atopic dermatitis	0.000138	0.00112	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—TLR2—atopic dermatitis	0.000137	0.00254	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—NFKBIA—atopic dermatitis	0.000137	0.00254	CbGpPWpGaD
Chloroquine—TLR9—Immune System—KIF3A—atopic dermatitis	0.000137	0.00254	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL6—atopic dermatitis	0.000136	0.00252	CbGpPWpGaD
Chloroquine—Alopecia—Betamethasone—atopic dermatitis	0.000135	0.0011	CcSEcCtD
Chloroquine—Alopecia—Dexamethasone—atopic dermatitis	0.000135	0.0011	CcSEcCtD
Chloroquine—Convulsion—Hydrocortisone—atopic dermatitis	0.000135	0.0011	CcSEcCtD
Chloroquine—TNF—Ceramide signaling pathway—MAPK8—atopic dermatitis	0.000135	0.00249	CbGpPWpGaD
Chloroquine—Angioedema—Triamcinolone—atopic dermatitis	0.000134	0.00109	CcSEcCtD
Chloroquine—Angioedema—Methylprednisolone—atopic dermatitis	0.000134	0.00109	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—FCER2—atopic dermatitis	0.000134	0.00248	CbGpPWpGaD
Chloroquine—Hallucination—Prednisone—atopic dermatitis	0.000133	0.00108	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IL4—atopic dermatitis	0.000133	0.00245	CbGpPWpGaD
Chloroquine—Anxiety—Hydrocortisone—atopic dermatitis	0.000132	0.00108	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000132	0.00244	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00013	0.00106	CcSEcCtD
Chloroquine—TNF—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.00013	0.00241	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—CASP8—atopic dermatitis	0.00013	0.0024	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—CASP8—atopic dermatitis	0.00013	0.0024	CbGpPWpGaD
Chloroquine—Vomiting—Tacrolimus—atopic dermatitis	0.00013	0.00105	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	0.000129	0.00239	CbGpPWpGaD
Chloroquine—Rash—Tacrolimus—atopic dermatitis	0.000129	0.00105	CcSEcCtD
Chloroquine—Headache—Tacrolimus—atopic dermatitis	0.000128	0.00104	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—IFNG—atopic dermatitis	0.000128	0.00236	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—atopic dermatitis	0.000128	0.00236	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—NFKBIA—atopic dermatitis	0.000128	0.00236	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000127	0.00103	CcSEcCtD
Chloroquine—Convulsion—Triamcinolone—atopic dermatitis	0.000127	0.00103	CcSEcCtD
Chloroquine—Convulsion—Methylprednisolone—atopic dermatitis	0.000127	0.00103	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	0.000125	0.00231	CbGpPWpGaD
Chloroquine—Anxiety—Methylprednisolone—atopic dermatitis	0.000124	0.00101	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—CCL22—atopic dermatitis	0.000124	0.0023	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—CASP8—atopic dermatitis	0.000124	0.00229	CbGpPWpGaD
Chloroquine—Angioedema—Betamethasone—atopic dermatitis	0.000122	0.000989	CcSEcCtD
Chloroquine—Angioedema—Dexamethasone—atopic dermatitis	0.000122	0.000989	CcSEcCtD
Chloroquine—Anorexia—Hydrocortisone—atopic dermatitis	0.000121	0.000986	CcSEcCtD
Chloroquine—Nausea—Tacrolimus—atopic dermatitis	0.000121	0.000985	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000121	0.00224	CbGpPWpGaD
Chloroquine—TNF—Cardiac Hypertrophic Response—MAPK8—atopic dermatitis	0.000121	0.00223	CbGpPWpGaD
Chloroquine—Confusional state—Methylprednisolone—atopic dermatitis	0.000121	0.00098	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CCL5—atopic dermatitis	0.00012	0.00222	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00012	0.000974	CcSEcCtD
Chloroquine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00012	0.000972	CcSEcCtD
Chloroquine—Hypotension—Hydrocortisone—atopic dermatitis	0.000119	0.000967	CcSEcCtD
Chloroquine—TNF—amb2 Integrin signaling—IL6—atopic dermatitis	0.000119	0.0022	CbGpPWpGaD
Chloroquine—Insomnia—Prednisolone—atopic dermatitis	0.000118	0.000958	CcSEcCtD
Chloroquine—Alopecia—Prednisone—atopic dermatitis	0.000118	0.000957	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—NFKBIA—atopic dermatitis	0.000117	0.00217	CbGpPWpGaD
Chloroquine—TLR9—Immune System—STAT6—atopic dermatitis	0.000117	0.00216	CbGpPWpGaD
Chloroquine—TLR9—Signaling by Insulin receptor—IL6—atopic dermatitis	0.000117	0.00216	CbGpPWpGaD
Chloroquine—Convulsion—Dexamethasone—atopic dermatitis	0.000116	0.000938	CcSEcCtD
Chloroquine—Convulsion—Betamethasone—atopic dermatitis	0.000116	0.000938	CcSEcCtD
Chloroquine—Insomnia—Hydrocortisone—atopic dermatitis	0.000115	0.000936	CcSEcCtD
Chloroquine—TNF—TNF alpha Signaling Pathway—CASP8—atopic dermatitis	0.000115	0.00213	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.000114	0.00211	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IL1B—atopic dermatitis	0.000114	0.0021	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CARD11—atopic dermatitis	0.000113	0.0021	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—atopic dermatitis	0.000113	0.0021	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IL2—atopic dermatitis	0.000113	0.0021	CbGpPWpGaD
Chloroquine—Anxiety—Betamethasone—atopic dermatitis	0.000113	0.000919	CcSEcCtD
Chloroquine—Anxiety—Dexamethasone—atopic dermatitis	0.000113	0.000919	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000113	0.00208	CbGpPWpGaD
Chloroquine—Hypotension—Methylprednisolone—atopic dermatitis	0.000112	0.000908	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—CCL27—atopic dermatitis	0.000111	0.00205	CbGpPWpGaD
Chloroquine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000111	0.000899	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IFNG—atopic dermatitis	0.00011	0.00204	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00011	0.000893	CcSEcCtD
Chloroquine—Vision blurred—Prednisone—atopic dermatitis	0.000109	0.000889	CcSEcCtD
Chloroquine—TNF—Adipogenesis—PPARA—atopic dermatitis	0.000109	0.00202	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.000109	0.00202	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000109	0.000884	CcSEcCtD
Chloroquine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000109	0.000884	CcSEcCtD
Chloroquine—Insomnia—Triamcinolone—atopic dermatitis	0.000108	0.000881	CcSEcCtD
Chloroquine—Insomnia—Methylprednisolone—atopic dermatitis	0.000108	0.000879	CcSEcCtD
Chloroquine—TNF—MAPK Signaling Pathway—BDNF—atopic dermatitis	0.000108	0.00199	CbGpPWpGaD
Chloroquine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000107	0.000873	CcSEcCtD
Chloroquine—Agitation—Prednisone—atopic dermatitis	0.000107	0.000867	CcSEcCtD
Chloroquine—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000107	0.000865	CcSEcCtD
Chloroquine—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000107	0.000865	CcSEcCtD
Chloroquine—Angioedema—Prednisone—atopic dermatitis	0.000106	0.000862	CcSEcCtD
Chloroquine—GSTA2—Metabolism—GLB1—atopic dermatitis	0.000106	0.00196	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CASP8—atopic dermatitis	0.000106	0.00196	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL6—atopic dermatitis	0.000106	0.00196	CbGpPWpGaD
Chloroquine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000105	0.000852	CcSEcCtD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—MAPK8—atopic dermatitis	0.000104	0.00193	CbGpPWpGaD
Chloroquine—Anorexia—Dexamethasone—atopic dermatitis	0.000104	0.000842	CcSEcCtD
Chloroquine—Anorexia—Betamethasone—atopic dermatitis	0.000104	0.000842	CcSEcCtD
Chloroquine—Urticaria—Prednisolone—atopic dermatitis	0.000104	0.000841	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—CXCL8—atopic dermatitis	0.000103	0.0019	CbGpPWpGaD
Chloroquine—Hypotension—Dexamethasone—atopic dermatitis	0.000102	0.000826	CcSEcCtD
Chloroquine—Hypotension—Betamethasone—atopic dermatitis	0.000102	0.000826	CcSEcCtD
Chloroquine—GSTA2—Metabolism—ADSL—atopic dermatitis	0.000102	0.00188	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.000101	0.00187	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000101	0.00187	CbGpPWpGaD
Chloroquine—Urticaria—Hydrocortisone—atopic dermatitis	0.000101	0.000822	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	0.000101	0.00187	CbGpPWpGaD
Chloroquine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000101	0.000818	CcSEcCtD
Chloroquine—Convulsion—Prednisone—atopic dermatitis	0.000101	0.000817	CcSEcCtD
Chloroquine—TLR9—Toll-Like Receptors Cascades—IL6—atopic dermatitis	9.97e-05	0.00184	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL17—atopic dermatitis	9.95e-05	0.00184	CbGpPWpGaD
Chloroquine—Feeling abnormal—Triamcinolone—atopic dermatitis	9.89e-05	0.000803	CcSEcCtD
Chloroquine—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.86e-05	0.000801	CcSEcCtD
Chloroquine—TNF—Alzheimers Disease—IL1B—atopic dermatitis	9.85e-05	0.00182	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL1B—atopic dermatitis	9.85e-05	0.00182	CbGpPWpGaD
Chloroquine—Anxiety—Prednisone—atopic dermatitis	9.85e-05	0.0008	CcSEcCtD
Chloroquine—Insomnia—Dexamethasone—atopic dermatitis	9.84e-05	0.000799	CcSEcCtD
Chloroquine—Insomnia—Betamethasone—atopic dermatitis	9.84e-05	0.000799	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL2—atopic dermatitis	9.82e-05	0.00182	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	9.71e-05	0.0018	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—IL6—atopic dermatitis	9.57e-05	0.00177	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—NGF—atopic dermatitis	9.55e-05	0.00177	CbGpPWpGaD
Chloroquine—Urticaria—Triamcinolone—atopic dermatitis	9.53e-05	0.000774	CcSEcCtD
Chloroquine—Urticaria—Methylprednisolone—atopic dermatitis	9.51e-05	0.000772	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisone—atopic dermatitis	9.48e-05	0.00077	CcSEcCtD
Chloroquine—Abdominal pain—Methylprednisolone—atopic dermatitis	9.46e-05	0.000768	CcSEcCtD
Chloroquine—Decreased appetite—Betamethasone—atopic dermatitis	9.46e-05	0.000768	CcSEcCtD
Chloroquine—Decreased appetite—Dexamethasone—atopic dermatitis	9.46e-05	0.000768	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	9.4e-05	0.000763	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	9.4e-05	0.000763	CcSEcCtD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	9.35e-05	0.00173	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—NFKBIA—atopic dermatitis	9.17e-05	0.0017	CbGpPWpGaD
Chloroquine—Asthenia—Hydrocortisone—atopic dermatitis	9.14e-05	0.000742	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—IL1B—atopic dermatitis	9.04e-05	0.00167	CbGpPWpGaD
Chloroquine—Anorexia—Prednisone—atopic dermatitis	9.04e-05	0.000734	CcSEcCtD
Chloroquine—Pruritus—Hydrocortisone—atopic dermatitis	9.01e-05	0.000732	CcSEcCtD
Chloroquine—Feeling abnormal—Dexamethasone—atopic dermatitis	8.97e-05	0.000728	CcSEcCtD
Chloroquine—Feeling abnormal—Betamethasone—atopic dermatitis	8.97e-05	0.000728	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—KIF3A—atopic dermatitis	8.87e-05	0.00164	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CASP1—atopic dermatitis	8.84e-05	0.00163	CbGpPWpGaD
Chloroquine—Diarrhoea—Hydrocortisone—atopic dermatitis	8.72e-05	0.000708	CcSEcCtD
Chloroquine—Urticaria—Dexamethasone—atopic dermatitis	8.65e-05	0.000702	CcSEcCtD
Chloroquine—Urticaria—Betamethasone—atopic dermatitis	8.65e-05	0.000702	CcSEcCtD
Chloroquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	8.64e-05	0.0016	CbGpPWpGaD
Chloroquine—Asthenia—Triamcinolone—atopic dermatitis	8.61e-05	0.000699	CcSEcCtD
Chloroquine—Abdominal pain—Dexamethasone—atopic dermatitis	8.6e-05	0.000699	CcSEcCtD
Chloroquine—Abdominal pain—Betamethasone—atopic dermatitis	8.6e-05	0.000699	CcSEcCtD
Chloroquine—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	8.6e-05	0.00159	CbGpPWpGaD
Chloroquine—Asthenia—Methylprednisolone—atopic dermatitis	8.59e-05	0.000697	CcSEcCtD
Chloroquine—Insomnia—Prednisone—atopic dermatitis	8.57e-05	0.000696	CcSEcCtD
Chloroquine—Pruritus—Triamcinolone—atopic dermatitis	8.49e-05	0.000689	CcSEcCtD
Chloroquine—Pruritus—Methylprednisolone—atopic dermatitis	8.47e-05	0.000688	CcSEcCtD
Chloroquine—TLR9—Immune System—IL5—atopic dermatitis	8.38e-05	0.00155	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—atopic dermatitis	8.37e-05	0.00155	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	8.34e-05	0.00154	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	8.31e-05	0.00154	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	8.27e-05	0.00153	CbGpPWpGaD
Chloroquine—Decreased appetite—Prednisone—atopic dermatitis	8.24e-05	0.000669	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL10—atopic dermatitis	8.24e-05	0.00152	CbGpPWpGaD
Chloroquine—Rash—Prednisolone—atopic dermatitis	8.22e-05	0.000668	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—IL6—atopic dermatitis	8.19e-05	0.00151	CbGpPWpGaD
Chloroquine—Diarrhoea—Methylprednisolone—atopic dermatitis	8.19e-05	0.000665	CcSEcCtD
Chloroquine—Headache—Prednisolone—atopic dermatitis	8.17e-05	0.000664	CcSEcCtD
Chloroquine—Vomiting—Hydrocortisone—atopic dermatitis	8.1e-05	0.000658	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—NFKBIA—atopic dermatitis	8.06e-05	0.00149	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	8.03e-05	0.00149	CbGpPWpGaD
Chloroquine—Rash—Hydrocortisone—atopic dermatitis	8.03e-05	0.000652	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—CMA1—atopic dermatitis	8.02e-05	0.00148	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL11—atopic dermatitis	8.02e-05	0.00148	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IFNG—atopic dermatitis	8.01e-05	0.00148	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	8.01e-05	0.00148	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	8e-05	0.00148	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TLR2—atopic dermatitis	7.99e-05	0.00148	CbGpPWpGaD
Chloroquine—Headache—Hydrocortisone—atopic dermatitis	7.98e-05	0.000648	CcSEcCtD
Chloroquine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.87e-05	0.00146	CbGpPWpGaD
Chloroquine—Feeling abnormal—Prednisone—atopic dermatitis	7.81e-05	0.000634	CcSEcCtD
Chloroquine—Asthenia—Betamethasone—atopic dermatitis	7.81e-05	0.000634	CcSEcCtD
Chloroquine—Asthenia—Dexamethasone—atopic dermatitis	7.81e-05	0.000634	CcSEcCtD
Chloroquine—Nausea—Prednisolone—atopic dermatitis	7.75e-05	0.000629	CcSEcCtD
Chloroquine—Pruritus—Dexamethasone—atopic dermatitis	7.7e-05	0.000625	CcSEcCtD
Chloroquine—Pruritus—Betamethasone—atopic dermatitis	7.7e-05	0.000625	CcSEcCtD
Chloroquine—Vomiting—Triamcinolone—atopic dermatitis	7.63e-05	0.000619	CcSEcCtD
Chloroquine—Vomiting—Methylprednisolone—atopic dermatitis	7.61e-05	0.000618	CcSEcCtD
Chloroquine—TNF—Apoptosis—CASP8—atopic dermatitis	7.58e-05	0.0014	CbGpPWpGaD
Chloroquine—Nausea—Hydrocortisone—atopic dermatitis	7.57e-05	0.000614	CcSEcCtD
Chloroquine—Rash—Triamcinolone—atopic dermatitis	7.56e-05	0.000614	CcSEcCtD
Chloroquine—Rash—Methylprednisolone—atopic dermatitis	7.55e-05	0.000613	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—STAT6—atopic dermatitis	7.54e-05	0.00139	CbGpPWpGaD
Chloroquine—Urticaria—Prednisone—atopic dermatitis	7.53e-05	0.000611	CcSEcCtD
Chloroquine—Headache—Triamcinolone—atopic dermatitis	7.51e-05	0.00061	CcSEcCtD
Chloroquine—TLR9—Immune System—CD79A—atopic dermatitis	7.51e-05	0.00139	CbGpPWpGaD
Chloroquine—Headache—Methylprednisolone—atopic dermatitis	7.5e-05	0.000609	CcSEcCtD
Chloroquine—Abdominal pain—Prednisone—atopic dermatitis	7.49e-05	0.000608	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—CXCL8—atopic dermatitis	7.45e-05	0.00138	CbGpPWpGaD
Chloroquine—Diarrhoea—Betamethasone—atopic dermatitis	7.45e-05	0.000605	CcSEcCtD
Chloroquine—Diarrhoea—Dexamethasone—atopic dermatitis	7.45e-05	0.000605	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	7.37e-05	0.00136	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CASP8—atopic dermatitis	7.27e-05	0.00134	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL1B—atopic dermatitis	7.15e-05	0.00132	CbGpPWpGaD
Chloroquine—Nausea—Triamcinolone—atopic dermatitis	7.13e-05	0.000579	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IL2—atopic dermatitis	7.12e-05	0.00132	CbGpPWpGaD
Chloroquine—Nausea—Methylprednisolone—atopic dermatitis	7.11e-05	0.000577	CcSEcCtD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	7.11e-05	0.00131	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—CASP8—atopic dermatitis	7.11e-05	0.00131	CbGpPWpGaD
Chloroquine—Vomiting—Betamethasone—atopic dermatitis	6.92e-05	0.000562	CcSEcCtD
Chloroquine—Vomiting—Dexamethasone—atopic dermatitis	6.92e-05	0.000562	CcSEcCtD
Chloroquine—Rash—Dexamethasone—atopic dermatitis	6.86e-05	0.000557	CcSEcCtD
Chloroquine—Rash—Betamethasone—atopic dermatitis	6.86e-05	0.000557	CcSEcCtD
Chloroquine—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	6.86e-05	0.00127	CbGpPWpGaD
Chloroquine—Headache—Betamethasone—atopic dermatitis	6.82e-05	0.000554	CcSEcCtD
Chloroquine—Headache—Dexamethasone—atopic dermatitis	6.82e-05	0.000554	CcSEcCtD
Chloroquine—Asthenia—Prednisone—atopic dermatitis	6.8e-05	0.000552	CcSEcCtD
Chloroquine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	6.72e-05	0.00124	CbGpPWpGaD
Chloroquine—Pruritus—Prednisone—atopic dermatitis	6.71e-05	0.000545	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—IL6—atopic dermatitis	6.66e-05	0.00123	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	6.54e-05	0.00121	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR3—atopic dermatitis	6.54e-05	0.00121	CbGpPWpGaD
Chloroquine—Diarrhoea—Prednisone—atopic dermatitis	6.49e-05	0.000527	CcSEcCtD
Chloroquine—Nausea—Dexamethasone—atopic dermatitis	6.47e-05	0.000525	CcSEcCtD
Chloroquine—Nausea—Betamethasone—atopic dermatitis	6.47e-05	0.000525	CcSEcCtD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	6.41e-05	0.00119	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	6.27e-05	0.00116	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL18—atopic dermatitis	6.15e-05	0.00114	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD8A—atopic dermatitis	6.06e-05	0.00112	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	6.05e-05	0.00112	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	6.05e-05	0.00112	CbGpPWpGaD
Chloroquine—Vomiting—Prednisone—atopic dermatitis	6.03e-05	0.000489	CcSEcCtD
Chloroquine—Rash—Prednisone—atopic dermatitis	5.98e-05	0.000485	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—CD4—atopic dermatitis	5.97e-05	0.0011	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	5.96e-05	0.0011	CbGpPWpGaD
Chloroquine—Headache—Prednisone—atopic dermatitis	5.94e-05	0.000482	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—NPS—atopic dermatitis	5.83e-05	0.00108	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TAC1—atopic dermatitis	5.83e-05	0.00108	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	5.75e-05	0.00106	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.72e-05	0.00106	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCR3—atopic dermatitis	5.71e-05	0.00106	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	5.7e-05	0.00105	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.68e-05	0.00105	CbGpPWpGaD
Chloroquine—Nausea—Prednisone—atopic dermatitis	5.63e-05	0.000457	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—IL5—atopic dermatitis	5.42e-05	0.001	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—IL1B—atopic dermatitis	5.39e-05	0.000997	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IL6—atopic dermatitis	5.29e-05	0.000979	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—MAPK8—atopic dermatitis	5.27e-05	0.000975	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.21e-05	0.000963	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—IL6—atopic dermatitis	5.11e-05	0.000945	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—MAPK8—atopic dermatitis	5.06e-05	0.000935	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—MAPK8—atopic dermatitis	4.94e-05	0.000914	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	4.84e-05	0.000896	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	4.7e-05	0.00087	CbGpPWpGaD
Chloroquine—TLR9—Immune System—NFKBIA—atopic dermatitis	4.7e-05	0.000868	CbGpPWpGaD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	4.63e-05	0.000856	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL10—atopic dermatitis	4.62e-05	0.000854	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	4.5e-05	0.000833	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.46e-05	0.000825	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	4.32e-05	0.000799	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	4.3e-05	0.000796	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.26e-05	0.000787	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CASP8—atopic dermatitis	4.24e-05	0.000783	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL6—atopic dermatitis	4.19e-05	0.000774	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCL5—atopic dermatitis	3.97e-05	0.000735	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—IL6—atopic dermatitis	3.87e-05	0.000716	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—PPARA—atopic dermatitis	3.76e-05	0.000695	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—NGF—atopic dermatitis	3.68e-05	0.000681	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	3.67e-05	0.000679	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IFNG—atopic dermatitis	3.6e-05	0.000666	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CCR5—atopic dermatitis	3.58e-05	0.000662	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD4—atopic dermatitis	3.48e-05	0.000643	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PPARA—atopic dermatitis	3.44e-05	0.000636	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.35e-05	0.000619	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—IL6—atopic dermatitis	3.23e-05	0.000597	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL1B—atopic dermatitis	3.21e-05	0.000594	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL2—atopic dermatitis	3.2e-05	0.000592	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.14e-05	0.00058	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.12e-05	0.000576	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—NFKBIA—atopic dermatitis	3.04e-05	0.000561	CbGpPWpGaD
Chloroquine—TLR9—Immune System—MAPK8—atopic dermatitis	2.95e-05	0.000545	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.89e-05	0.000534	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.81e-05	0.00052	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—GLB1—atopic dermatitis	2.68e-05	0.000495	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ADSL—atopic dermatitis	2.57e-05	0.000475	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—GLB1—atopic dermatitis	2.53e-05	0.000468	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ADSL—atopic dermatitis	2.42e-05	0.000448	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—GLB1—atopic dermatitis	2.32e-05	0.000429	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ADSL—atopic dermatitis	2.22e-05	0.000411	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—CXCL8—atopic dermatitis	2.17e-05	0.0004	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL2—atopic dermatitis	2.07e-05	0.000383	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—GLB1—atopic dermatitis	2.02e-05	0.000373	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.96e-05	0.000362	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ADSL—atopic dermatitis	1.94e-05	0.000358	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MAPK8—atopic dermatitis	1.9e-05	0.000352	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.9e-05	0.000352	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL6—atopic dermatitis	1.88e-05	0.000348	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.84e-05	0.000341	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.82e-05	0.000337	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.69e-05	0.000312	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.55e-05	0.000286	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.4e-05	0.000259	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—IL6—atopic dermatitis	1.33e-05	0.000246	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.24e-05	0.00023	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL6—atopic dermatitis	1.22e-05	0.000225	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.19e-05	0.000221	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PPARA—atopic dermatitis	8.69e-06	0.000161	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PPARA—atopic dermatitis	8.21e-06	0.000152	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PPARA—atopic dermatitis	7.52e-06	0.000139	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PPARA—atopic dermatitis	6.55e-06	0.000121	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PPARA—atopic dermatitis	6.18e-06	0.000114	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.04e-06	7.47e-05	CbGpPWpGaD
